Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• ErenumabMODERAT

  Mengonsumsi Erenumab bersama Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Erenumab is combined with Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

• TheophyllineMODERAT

  Penggunaan bersama Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen dapat meningkatkan konsentrasi Theophylline dalam serum (darah).

  Tampilan ahli

  The serum concentration of Theophylline can be increased when it is combined with Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

• 2-MethoxyethanolRINGAN

  Penggunaan bersama 2-Methoxyethanol dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with 2-Methoxyethanol.

• 9-(N-methyl-L-isoleucine)-cyclosporin ARINGAN

  Penggunaan bersama 9-(N-methyl-L-isoleucine)-cyclosporin A dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with 9-(N-methyl-L-isoleucine)-cyclosporin A.

• AbataceptRINGAN

  Penggunaan bersama Abatacept dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Abatacept.

• AbetimusRINGAN

  Penggunaan bersama Abetimus dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Abetimus.

• ActeosideRINGAN

  Penggunaan bersama Acteoside dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Acteoside.

• AdalimumabRINGAN

  Penggunaan bersama Adalimumab dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Adalimumab.

• AfelimomabRINGAN

  Penggunaan bersama Afelimomab dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Afelimomab.

• AldesleukinRINGAN

  Penggunaan bersama Aldesleukin dapat menurunkan efektivitas Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen.

  Tampilan ahli

  The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Aldesleukin.